D
Guardion Health Sciences, Inc.
GHSI
OTC PK
E
Sell
5/22/2024Downgrade
Guardion Health Sciences, Inc. (GHSI) was downgraded to E+ from D+ on 5/22/2024 due to a significant decline in the efficiency index, growth index and valuation index. Net income declined 1,217.66% from $424.7 to -$4.75M, earnings per share declined from $0.3361 to -$3.71, and total capital declined 58.09% from $8.15M to $3.41M.
Guardion Health Sciences, Inc. (GHSI) was downgraded to E+ from D+ on 5/22/2024 due to a significant decline in the efficiency index, growth index and valuation index. Net income declined 1,217.66% from $424.7 to -$4.75M, earnings per share declined from $0.3361 to -$3.71, and total capital declined 58.09% from $8.15M to $3.41M.
D
Sell
4/11/2024Upgraded
Guardion Health Sciences, Inc. (GHSI) was upgraded to D+ from D- on 4/11/2024 due to a significant increase in the efficiency index, growth index and total return index. Earnings per share increased from $0.29 to $0.3361, net income increased 13.98% from $372.6 to $424.7, and EBIT increased 10.44% from -$772.9 to -$692.2.
Guardion Health Sciences, Inc. (GHSI) was upgraded to D+ from D- on 4/11/2024 due to a significant increase in the efficiency index, growth index and total return index. Earnings per share increased from $0.29 to $0.3361, net income increased 13.98% from $372.6 to $424.7, and EBIT increased 10.44% from -$772.9 to -$692.2.
D
Sell
8/15/2023Upgraded
Guardion Health Sciences, Inc. (GHSI) was upgraded to D- from E+ on 8/15/2023 due to an increase in the volatility index and total return index.
Guardion Health Sciences, Inc. (GHSI) was upgraded to D- from E+ on 8/15/2023 due to an increase in the volatility index and total return index.
E
Sell
3/14/2023Downgrade
Guardion Health Sciences, Inc. (GHSI) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
Guardion Health Sciences, Inc. (GHSI) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/9/2023Upgraded
Guardion Health Sciences, Inc. (GHSI) was upgraded to D from E+ on 2/9/2023 due to an increase in the total return index and volatility index.
Guardion Health Sciences, Inc. (GHSI) was upgraded to D from E+ on 2/9/2023 due to an increase in the total return index and volatility index.
E
Sell
2/8/2023Downgrade
Guardion Health Sciences, Inc. (GHSI) was downgraded to E+ from D on 2/8/2023 due to a decline in the growth index. Total revenue declined 18.67% from $3.28M to $2.66M, and EBIT declined 1.08% from -$1.71M to -$1.73M.
Guardion Health Sciences, Inc. (GHSI) was downgraded to E+ from D on 2/8/2023 due to a decline in the growth index. Total revenue declined 18.67% from $3.28M to $2.66M, and EBIT declined 1.08% from -$1.71M to -$1.73M.
D
Sell
8/15/2022Upgraded
Guardion Health Sciences, Inc. (GHSI) was upgraded to D from D- on 8/15/2022 due to a major increase in the growth index and total return index. Earnings per share increased from -$0.0669 to -$0.0277, total revenue increased 37.35% from $2.38M to $3.28M, and EBIT increased 34.06% from -$2.6M to -$1.71M.
Guardion Health Sciences, Inc. (GHSI) was upgraded to D from D- on 8/15/2022 due to a major increase in the growth index and total return index. Earnings per share increased from -$0.0669 to -$0.0277, total revenue increased 37.35% from $2.38M to $3.28M, and EBIT increased 34.06% from -$2.6M to -$1.71M.
D
Sell
5/5/2022Upgraded
Guardion Health Sciences, Inc. (GHSI) was upgraded to D- from E+ on 5/5/2022 due to an increase in the total return index.
Guardion Health Sciences, Inc. (GHSI) was upgraded to D- from E+ on 5/5/2022 due to an increase in the total return index.
E
Sell
4/20/2022Downgrade
Guardion Health Sciences, Inc. (GHSI) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index and volatility index.
Guardion Health Sciences, Inc. (GHSI) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index and volatility index.
D
Sell
4/18/2022Downgrade
Guardion Health Sciences, Inc. (GHSI) was downgraded to D- from D on 4/18/2022 due to a noticeable decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.1234 to -$0.5923, and total revenue declined 16.55% from $3.15M to $2.63M.
Guardion Health Sciences, Inc. (GHSI) was downgraded to D- from D on 4/18/2022 due to a noticeable decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.1234 to -$0.5923, and total revenue declined 16.55% from $3.15M to $2.63M.
D
Sell
3/30/2022Upgraded
Guardion Health Sciences, Inc. (GHSI) was upgraded to D from D- on 3/30/2022 due to an increase in the volatility index.
Guardion Health Sciences, Inc. (GHSI) was upgraded to D from D- on 3/30/2022 due to an increase in the volatility index.
D
Sell
3/15/2022Downgrade
Guardion Health Sciences, Inc. (GHSI) was downgraded to D- from D on 3/15/2022 due to a noticeable decline in the growth index, total return index and volatility index. EBIT declined 10.94% from -$2.44M to -$2.7M.
Guardion Health Sciences, Inc. (GHSI) was downgraded to D- from D on 3/15/2022 due to a noticeable decline in the growth index, total return index and volatility index. EBIT declined 10.94% from -$2.44M to -$2.7M.
D
Sell
11/9/2021Upgraded
Guardion Health Sciences, Inc. (GHSI) was upgraded to D from E+ on 11/9/2021 due to an increase in the total return index.
Guardion Health Sciences, Inc. (GHSI) was upgraded to D from E+ on 11/9/2021 due to an increase in the total return index.
E
Sell
11/8/2021Downgrade
Guardion Health Sciences, Inc. (GHSI) was downgraded to E+ from D on 11/8/2021 due to a decline in the total return index and volatility index.
Guardion Health Sciences, Inc. (GHSI) was downgraded to E+ from D on 11/8/2021 due to a decline in the total return index and volatility index.
D
Sell
1/25/2021Upgraded
Guardion Health Sciences, Inc. (GHSI) was upgraded to D from D- on 1/25/2021 due to a noticeable increase in the total return index and volatility index.
Guardion Health Sciences, Inc. (GHSI) was upgraded to D from D- on 1/25/2021 due to a noticeable increase in the total return index and volatility index.
D
Sell
11/16/2020Downgrade
Guardion Health Sciences, Inc. (GHSI) was downgraded to D- from D on 11/16/2020 due to a large decline in the growth index, volatility index and total return index. Earnings per share declined from -$0.0082 to -$0.0243, total revenue declined 78.74% from $1.19M to $253.2, and EBIT declined 23.34% from -$1.73M to -$2.13M.
Guardion Health Sciences, Inc. (GHSI) was downgraded to D- from D on 11/16/2020 due to a large decline in the growth index, volatility index and total return index. Earnings per share declined from -$0.0082 to -$0.0243, total revenue declined 78.74% from $1.19M to $253.2, and EBIT declined 23.34% from -$1.73M to -$2.13M.
D
Sell
5/1/2020Upgraded
Guardion Health Sciences, Inc. (GHSI) was upgraded to D from D- on 5/1/2020 due to an increase in the solvency index, volatility index and growth index.
Guardion Health Sciences, Inc. (GHSI) was upgraded to D from D- on 5/1/2020 due to an increase in the solvency index, volatility index and growth index.
D
Sell
3/31/2020Upgraded
Guardion Health Sciences, Inc. (GHSI) was upgraded to D- from E+ on 3/31/2020 due to an increase in the volatility index, solvency index and total return index. The quick ratio increased from 12.15 to 27.29, and debt to equity declined from 0.02 to 0.01.
Guardion Health Sciences, Inc. (GHSI) was upgraded to D- from E+ on 3/31/2020 due to an increase in the volatility index, solvency index and total return index. The quick ratio increased from 12.15 to 27.29, and debt to equity declined from 0.02 to 0.01.
E
Sell
3/17/2020Downgrade
Guardion Health Sciences, Inc. (GHSI) was downgraded to E+ from D- on 3/17/2020 due to a decline in the volatility index.
Guardion Health Sciences, Inc. (GHSI) was downgraded to E+ from D- on 3/17/2020 due to a decline in the volatility index.
D
Sell
2/27/2020Upgraded
Guardion Health Sciences, Inc. (GHSI) was upgraded to D- from E+ on 2/27/2020 due to an increase in the volatility index and total return index.
Guardion Health Sciences, Inc. (GHSI) was upgraded to D- from E+ on 2/27/2020 due to an increase in the volatility index and total return index.
E
Sell
2/12/2020Downgrade
Guardion Health Sciences, Inc. (GHSI) was downgraded to E+ from D- on 2/12/2020 due to a decline in the volatility index and total return index.
Guardion Health Sciences, Inc. (GHSI) was downgraded to E+ from D- on 2/12/2020 due to a decline in the volatility index and total return index.
D
Sell
1/2/2020Upgraded
Guardion Health Sciences, Inc. (GHSI) was upgraded to D- from E on 1/2/2020 due to an increase in the growth index, efficiency index and valuation index. Total capital increased 62.91% from $5.29M to $8.63M, earnings per share increased from -$0.1353 to -$0.0662, and net income increased 21.75% from -$3.05M to -$2.39M.
Guardion Health Sciences, Inc. (GHSI) was upgraded to D- from E on 1/2/2020 due to an increase in the growth index, efficiency index and valuation index. Total capital increased 62.91% from $5.29M to $8.63M, earnings per share increased from -$0.1353 to -$0.0662, and net income increased 21.75% from -$3.05M to -$2.39M.
E
Sell
10/1/2019Upgraded
Guardion Health Sciences, Inc. (GHSI) was upgraded to E from E- on 10/1/2019 due to a major increase in the solvency index, valuation index and total return index. The quick ratio increased from 0.12 to 4.55, and debt to equity declined from 0.13 to 0.03.
Guardion Health Sciences, Inc. (GHSI) was upgraded to E from E- on 10/1/2019 due to a major increase in the solvency index, valuation index and total return index. The quick ratio increased from 0.12 to 4.55, and debt to equity declined from 0.13 to 0.03.
E
Sell
7/1/2019None
Guardion Health Sciences, Inc. (GHSI) was downgraded to E- from U on 07/01/2019.
Guardion Health Sciences, Inc. (GHSI) was downgraded to E- from U on 07/01/2019.
